AAPS 2012 in Chicago

Xcelience plans EU clinical trial supply expansion after opening new US plant

Xcelience plans to distribute clinical trial supplies outside the US following the opening of its new facility in Tampa, FL

Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.

Keep ingredients to a minimum in paediatric formulation to reduce risk of overdose, say experts at AAPS

Low API and excipient volumes vital to win authorisation under EU PIP says EMA

Catalent believes collaboration amongst industry and academia will drive drug delivery

Catalent says sharing with industry will not dull competetive edge

Boosting communication between industry and academia is the way to advance drug delivery, says Catalent

Catalent aims to boost drug delivery through industry-academia partnership

A new QbD paradigm: keep R&D equipment when producing on commercial scale

Eliminate scale up by using R&D equipment for commercial production: GSK

Capsugel expands liquid fill capsule capabilities

Bend Research hunting new partnerships

Bend Research hunting new partnerships to boost bioavailability offering

Biosimilar regs and ref drugs differ world, says Pfizer

Remember regional Biosimilar regs and ref drugs differ, says Pfizer

Finding information about production at CMO plants in emerging markets is often confusing, according to the FDA

Emerging market CMOs and their customers must make info easily available: FDA

GMP requirements in Peru

Peru's GMP requirements mean delayed approvals, says expert

More AAPS 2012 in Chicago